a company, which engages in discovery and development of breakthrough treatments for human disease
Industry Biotechnology
A.I.dvisor indicates that over the last year, LXRX has been loosely correlated with ABCL. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if LXRX jumps, then ABCL could also see price increases.
Ticker / NAME | Correlation To LXRX | 1D Price Change % | ||
---|---|---|---|---|
LXRX | 100% | -6.94% | ||
ABCL - LXRX | 51% Loosely correlated | -2.34% | ||
ADPT - LXRX | 50% Loosely correlated | -4.47% | ||
NTLA - LXRX | 50% Loosely correlated | -3.65% | ||
BEAM - LXRX | 48% Loosely correlated | -8.55% | ||
VIR - LXRX | 47% Loosely correlated | -5.81% | ||
More |
Ticker / NAME | Correlation To LXRX | 1D Price Change % |
---|---|---|
LXRX | 100% | -6.94% |
drugs theme (265 stocks) | 47% Loosely correlated | +5.37% |
biotechnology theme (248 stocks) | 45% Loosely correlated | +5.56% |
human theme (15 stocks) | 31% Poorly correlated | +1.59% |